SCHEMBL24737476

SCHEMBL24737476

CC(NSC(C)(C)C)c1cn2cc(C3CC3)cc(N3CC4CC4C3=O)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29302557 0.84 — —
SCHEMBL24737475 0.83 BTK (0.31) —
SCHEMBL29880188 0.83 BTK (0.31) —
SCHEMBL29304600 0.77 — —
SCHEMBL24738864 0.73 BTK (0.32) —
SCHEMBL24737473 0.73 BTK (0.32) —
SCHEMBL29302767 0.70 — —
SCHEMBL24739895 0.70 BTK (0.31) —
Hydrochloric Acid SCHEMBL29879969 0.69 BTK (0.30) —
SCHEMBL24738160 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022197758-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback